Pegylated liposomal doxorubincin combined with ifosfamide as first-line treatment for patients with advanced or metastatic soft tissue sarcoma
Background and purpose: Patient with metastatic soft tissue sarcoma has a poor prognosis with median survival time of less than 1 year. Doxorubicin combined with ifosfamide (IFO) (AI regimen) is frequently used in the first-line treatment for patients with metastatic soft tissue sarcoma. Pegylated l...
שמור ב:
| Principais autores: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Editorial Office of China Oncology
2017-09-01
|
| סדרה: | Zhongguo aizheng zazhi |
| נושאים: | |
| גישה מקוונת: | http://www.china-oncology.com/thesisDetails#10.19401/j.cnki.1007-3639.2017.09.002 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|